Informa Markets to organise PharmaLytica in Mumbai
The show will be marked by over 300 brands and anticipates more than 7,000 trade visitors and 30 conference speakers
Informa Markets is going to organise the 8th edition of the PharmaLytica Expo from 1st-3rd June, 2022, in Mumbai. The three-day expo will focus on companies abreast with innovations in the growing businesses of India’s pharma industry and achieve the vision of becoming a $130 billion industry by 2030, the company said in a statement.
It also said that the expo, with over 300 brands, will present the entire value-added chain in niche segments within the pharma industry and enable the community to pick up on the latest industry trends and innovations and conduct business with analytical, laboratory, machinery, packaging and other allied industries. The show will be marked by over 300 brands and anticipates more than 7,000 trade visitors and 30 conference speakers. The key players include Shimadzu, Thermolab, Agilent, Thermo Fisher, Saksham Scientific, SRICO, Newtronics, Mack Pharmatech, Komal Scientific, Sanosil Biotech, Toshvin Analytical, PCI Analytics, Sanitt Equipment and Elmach, among many others.
The two-day conference also marks the event to discuss and deliberate on industry topics, challenges and opportunities towards digitalisation, strategies for maintaining a global supply chain in a constrained manner and transforming labs into smart technological labs. The conference will cover topics like API, machinery and manufacturing, lab and analytical, QR code, supply chain, packaging and labelling, and sterilisation. Besides, B2B matchmaking and B2B networking will enable industry stalwarts, pharma leaders, technical heads and plant heads, medical heads and scientists, marketing and strategy leaders, R&D heads and technocrats, engineering and production professionals, purchase and packaging professionals, regulatory affairs professionals and others to interact and network with exhibitors from across the industry to discuss strategies to charter next phase of growth in the industry.